Filing metadata

Accession number
0001209191-21-069960
Form type
Form 4
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Dec 16, 2021
Reporting period
Dec 14, 2021
Description
Insider transaction

Explore SEC Filings Hub